MYBL1 and adrenal cortex carcinoma: Mitani et al. [6] identified that a cohort of ACC harboring MYB or MYBL1 breakpoint after exon 11 exhibits a distinct expression profile, which differs from tumors with fusions at exon 8 or 9.